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As of the 2007-2008 National Health and Nutrition Examination Survey, 34 
percent of adults – or over 72 million people - were obese, having a BMI greater than 
30. And childhood obesity has been catching up, strongly implying that this epidemic will 
only continue to grow for the foreseeable future. The current “obesogenic” environment 
is often cited as the major cause of the obesity epidemic. However, the fact that a large 
percentage of the population has not become obese could imply that a gene-
environment interaction contributes. For instance, this differential response to the 
obesogenic environment suggests one’s inherited physiological makeup (which itself is 
modulated by environment) either resists or favors obesity. Given the powerful influence 
of the current environment, if one’s physiology favors obesity it takes tremendous 
discipline to avoid excessive caloric intake and weight gain.  
Having obesity might not be so unfortunate if weight gain and increased fat mass 
were the only consequences. However, as has been clear for some time now, obesity is 
associated with numerous sequelae such as diabetes, cardiovascular disease, and 
cancer [1]. Further, individuals that develop proportionately large visceral abdominal fat 
stores are more likely to experience the morbidity and mortality associated with these 
obesity-related diseases [2]. Regrettably, despite the fact that these consequences 
have been known for a long time, no satisfactory non-invasive treatment for obesity has 
been developed. As a consequence, large numbers of people with obesity have been 
driven to undergo expensive and risky bariatric surgical procedures. One of these 
surgeries, gastric bypass, has been fairly effective at reducing body weight, and it has 
also turned out to be useful for treating type 2 diabetes [3]. The mechanism underlying 
these effects is not fully understood, but appears to involve many factors, including 






decreases in consumption of high calorie foods, meal size and nutrient absorption as 
well as changes in anorexigenic and orexigenic hormone levels, increased energy 
expenditure, and altered vagal gastrointestinal (GI) innervation [4]. It may be that the 
multifactorial nature of the effects of gastric bypass is a key to its success at reducing 
body weight.  
Before bariatric procedures became popular, truncal vagotomy, involving division 
of the right and left vagal trunks below the diaphragm was employed to treat morbid 
obesity [5]. However, the interruption of vagal pre- motor axons as part of the vagotomy 
procedure caused gastric stasis and “dumping” of food from the stomach to the 
intestine, which resulted in unpleasant sensations, including nausea. One way to 
overcome the adverse side effects of vagotomy and retain some of the benefits would 
be to reduce or avoid damage to the vagal pre-motor axons. Indeed, selective sensory 
vagotomy appears to retain some of the benefits as it has been shown to reduce food 
intake, body weight and fat accumulation in rodent obesity models [6-7]. Moreover, in 
one of these studies sensory vagotomy reduced the excess abdominal visceral fat 
found in aging rats [7]. Stearns et al. took this approach further by distinguishing the 
effects of sensory vagotomy on different fat depots in rats subjected to diet-induced 
obesity (DIO) [8]. They produced sensory vagotomy by applying capsaicin to the 
abdominal vagal branches and compared the effect of this treatment on DIO in rats fed 
a high-energy “Western diet” for 11 months with the effects of truncal vagotomy and 
sham surgery.  Interestingly, although sensory vagotomy produced only a small, non-
significant reduction in body weight, it also led to a modest, but significant and selective 
18% reduction in visceral abdominal fat compared to controls. Given the association of 






this fat depot with several causes of morbidity and mortality that can result from obesity 
this is an important finding. Moreover, as the authors pointed out, even this fairly small 
effect of sensory vagotomy on visceral fat could produce significant decreases in 
morbidity and mortality. For instance, in patients with a large visceral fat depot, small 
changes in its size can have a big influence on overall mortality risk [9]. Stearns et al. [8] 
further suggested that sensory vagotomy could provide a valuable adjunct to bariatric 
surgery by enhancing its ability to reduce body fat, and in particular visceral fat. 
Consistent with this possibility, truncal vagotomy has been used successfully as an 
adjunct to gastroplasty to augment weight loss [10].  
Another important implication of the findings of Stearns et al. [8] is that vagal GI 
afferents may contribute to DIO. However, this interpretation goes against traditional 
views of vagal GI sensory function in two ways. First, the main roles of vagal afferents 
are thought to be inhibition of food intake [11] and regulation of vago-vagal digestive 
reflexes [12] - not facilitation of food intake or weight gain. Secondly, the influences of 
vagal afferents on food intake and body weight are thought to act on a short-term, or 
meal-by-meal basis - not to accrue over the long-term [11].  
One possible route by which vagal afferents could facilitate food intake and 
weight gain involves alterations to their control of vago-vagal GI reflexes. For example, 
accommodation is activated by food-induced stretch of the esophagus and forestomach 
[13]. It relaxes the stomach wall, which is contracted between meals. This allows the 
stomach to accept a meal without significantly increasing intragastric pressure. If this 
relaxation were exaggerated, it could permit consumption of larger-than-normal meals 






before intragastric pressure increased sufficiently to activate vagal satiation signals, or 
to propel food into the intestine, which also activates these signals. Consistent with this 
possibility, loss of vagal afferents that innervate the forestomach in steel and Wv mutant 
mice led to reduced meal size, which could imply that this reduced innervation resulted 
in weaker activation of accommodation and thus reduced the stomach volume available 
to accept food (e.g., [14]). Also, increased meal size caused by knockout (KO) of brain-
derived neurotrophic factor (BDNF) in GI smooth muscle was associated with increased 
activation of gastric vagal pre-motor neurons, an effect consistent with augmentation of 
accommodation or gastric motility [15-16]. However, these suspected changes in vago-
vagal reflexes in steel, Wv and BDNF mutants need to be verified. As noted by Stearns 
et al. [8], a more direct pathway vagal afferents could utilize to promote abdominal 
obesity was identified in pilot experiments that suggested intestinal mucosal nerves 
were necessary for accumulation of visceral fat [17]. However, it remains to be 
determined whether vagal afferents are involved. 
Regarding the implication of the results of Stearns et al. [8] that vagal afferents 
contribute to the long-term accumulation of the visceral fat component of body weight, 
there are only a handful studies that have provided supporting evidence. Interestingly, 
the vagal manipulations in these studies have typically occurred in conjunction with 
alterations to the CNS feeding regulatory circuit, suggesting these alterations are 
needed to reveal a long-term vagal afferent role. These studies involved reductions in 
central and peripheral CCK receptors that resulted in obesity [18], 
intracerebroventricular leptin injection paired with subthreshold peripheral CCK infusion 
that reduced body weight [19], and partial reduction of central BDNF levels combined 






with KO of BDNF in GI smooth muscle that caused obesity [16]. These peripheral CCK 
and BDNF effects presumably involved altered vagal afferent signaling, but this needs 
to be verified. Additionally, consumption of a high-energy diet by neurotrophin-4 KO 
mice, which lack most of the vagal afferents that innervate the smooth muscle of the 
small intestine, revealed an increased hyperphagia compared to controls [20]. A 
possibility to consider is that the long-term effects associated with the loss of vagal 
afferents in neurotrophin-4 mutants and in the DIO rats of Strearns et al. [8] involved 
changes to the CNS feeding regulatory circuit. High-energy diets can reduce the levels 
of anorexigens, including BDNF, in CNS nuclei that regulate feeding and body weight 
[21], and in some instances these reductions have been demonstrated to contribute to 
hyperphagia and obesity [22]. Thus, if the high-energy diets fed to the neurotrophin-4 
mutants or the DIO rats of Stearns et al. [8] reduced anorexigen levels in key CNS 
nuclei, then these reductions may have combined with the effects of the missing vagal 
GI afferents in these animals to produce long-term effects on body weight. Finally, as 
noted by Stearns et al. [8], clinical studies using chronic electrical stimulation of the 
cervical vagus observed weight loss in depressed patients with obesity, which is 
consistent with a long-term role for vagal afferents in body weight regulation. 
Future studies will make valuable progress by building on the results and 
experimental design of Stearns et al. For example, to better understand the 
contributions of changes in feeding behavior and energy expenditure to the effects of 
vagotomy, it would be valuable to characterize them early in the dynamic phase of 
weight gain. Obesity can have its own effects on food intake and energy expenditure 
that become confounded with the effects of vagotomy on these variables. Therefore, 






measuring them prior to development of obesity will help establish whether changes in 
these variables are a cause or a consequence of obesity. Another valuable addition 
would be to have two reference groups that are fed a balanced diet with its components 
matched as closely as possible to those of the high-energy diet: one group that receives 
no treatment and another that receives vagotomy. These groups provide baselines that 
permit one to distinguish, for example, the actual degree of obesity in each group, rather 
than just the relative degree. Also, the proportions of the obesity and excess visceral fat 
due to aging [7] vs. diet [8] could be distinguished, both with and without vagotomy. 
Further, since capsaicin produces only a partial loss of vagal GI afferents, it will be 
informative to assess residual vagal function in vagotomized animals before they are 
exposed to a high-energy diet, for example, by examining CCK suppression of meal 
size. In addition to confirming the success of the vagotomy procedure, these types of 
experiments could help identify the vagal sensory pathways that contribute to DIO. 
Finally, when lengthy postvagotomy survival times are involved, vagal afferents 
regenerate [23], and therefore, this should be examined because it could actually mask 
some of the beneficial effects of vagotomy on DIO.  
Studies that build on the findings of Stearns et al. [8] by considering these and 
possibly additional useful variations of the experimental design will bring us closer to 
knowing whether vagal GI afferents contribute to long-term regulation of food intake and 
body weight, and if so how they do this. Such progress will provide novel targets for 
gaining control over the excessive overeating and weight gain that has become so 
pervasive.  
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